Fine Particulate Matter Exposure and Risk of Major Adverse Cardiac and Cerebrovascular Events (MACCE) in

Chaiyawat Suppasilp1, Teeranan Angkananard2, Romen Samuel Rodis Wabina1

  • 1Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Global Heart
|March 23, 2026
PubMed
Abstract

Insights

Fine particulate matter (PM2.5) exposure significantly increases the risk of major adverse cardiac and cerebrovascular events (MACCE) in patients after percutaneous coronary intervention (PCI). Reducing PM2.5 is crucial for improving patient outcomes and lessening disease burden.

Area of Science:

  • Environmental Health
  • Cardiovascular Research
  • Public Health

Background:

  • Major adverse cardiac and cerebrovascular events (MACCE) are critical outcomes for patients undergoing percutaneous coronary intervention (PCI).
  • Limited evidence exists on the impact of fine particulate matter (PM2.5) on MACCE in this patient population.
  • Understanding environmental risk factors like PM2.5 is essential for improving cardiovascular care.

Purpose of the Study:

  • To investigate the association between fine particulate matter (PM2.5) exposure and the incidence of MACCE in Thai adults who underwent PCI.
  • To quantify the risk of MACCE associated with varying levels of PM2.5 exposure.
  • To inform public health strategies aimed at mitigating cardiovascular risks.

Main Methods:

  • Retrospective cohort study of 22,188 Thai adults undergoing PCI.
  • Cumulative PM2.5 exposure estimated using satellite data based on residential locations over a 12-month follow-up.
  • Multilevel survival model used to assess the association between PM2.5 and MACCE, adjusting for confounders.

Main Results:

  • A 1 µg/m³ increase in PM2.5 exposure was associated with a 45% increased risk of MACCE (aHR 1.45).
  • Higher seasonal PM2.5 exposure, particularly in Q3 (aHR 1.50), showed a significant association with MACCE.
  • 28.8% of patients experienced at least one MACCE during the median 11.97-month follow-up.

Conclusions:

  • Higher seasonal PM2.5 exposure is significantly associated with an increased risk of MACCE in patients post-PCI.
  • Findings highlight the urgent need for public health policies to reduce PM2.5 levels.
  • Reducing PM2.5 exposure can improve cardiovascular health outcomes and decrease the disease burden.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.3K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
436
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
733
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.2K
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
1.0K